These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 2839926)

  • 41. Evaluation of safety and efficacy of DNA vaccines against bovine herpesvirus-1 (BoHV-1) in calves.
    Petrini S; Ramadori G; Corradi A; Borghetti P; Lombardi G; Villa R; Bottarelli E; Guercio A; Amici A; Ferrari M
    Comp Immunol Microbiol Infect Dis; 2011 Jan; 34(1):3-10. PubMed ID: 19906427
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Comparison of the immunizing effectiveness of subunit vaccine and inactivated viral oil vaccine against infectious rhinotracheitis of cattle].
    Zuffa A; Zajac J; Zuffa T
    Vet Med (Praha); 1986 Apr; 31(4):209-18. PubMed ID: 3010533
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Protective effect of inactivated bovine herpesvirus-1 in calves experimentally infected with bovine herpesvirus-1 and Pasteurella haemolytica.
    Jericho KW; Loewen KG; Smithson SE; Kozub GC
    Res Vet Sci; 1991 Sep; 51(2):209-14. PubMed ID: 1664970
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Enhancement of infectious bovine keratoconjunctivitis by modified-live infectious bovine rhinotracheitis virus vaccine.
    George LW; Ardans A; Mihalyi J; Guerra MR
    Am J Vet Res; 1988 Nov; 49(11):1800-6. PubMed ID: 2854704
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Problems in the latency period following vaccination against infectious bovine rhinotracheitis virus (bovid herpesvirus 1)].
    Pastoret PP; Thiry E; Vindevogel H
    Dev Biol Stand; 1982; 52():455-61. PubMed ID: 6299855
    [No Abstract]   [Full Text] [Related]  

  • 46. Immune response to infectious bovine rhinotracheitis virus (IBRV) following natural infection or vaccination by intranasally or parenterally administered vaccines.
    Todd JD
    Dev Biol Stand; 1975; 28():526-9. PubMed ID: 165128
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Effect of maternal antibody upon vaccination with infectious bovine rhinotracheitis and bovine virus diarrhea vaccines.
    Menanteau-Horta AM; Ames TR; Johnson DW; Meiske JC
    Can J Comp Med; 1985 Jan; 49(1):10-4. PubMed ID: 2985214
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Persistence of antibodies and anamnestic response in calves vaccinated with inactivated infectious bovine rhinotracheitis virus and parainfluenza-3 virus vaccines.
    Sweat RL
    J Am Vet Med Assoc; 1983 Apr; 182(8):809-11. PubMed ID: 6303996
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Modification of active immunization with live bovine herpesvirus 1 vaccine by passive viral antibody.
    Patel JR; Shilleto RW
    Vaccine; 2005 Jul; 23(31):4023-8. PubMed ID: 15916839
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A recombinant bovine herpesvirus 5 defective in thymidine kinase and glycoprotein E is immunogenic for calves and confers protection upon homologous challenge and BoHV-1 challenge.
    Anziliero D; Santos CM; Brum MC; Weiblen R; Chowdhury SI; Flores EF
    Vet Microbiol; 2011 Dec; 154(1-2):14-22. PubMed ID: 22019288
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Development of a disease control programme based on the use of an inactivated vaccine against infectious bovine rhinotracheitis.
    Pospísil Z; Krejcí J; Jínek P; Lány P; Zendulková D; Cíhal P
    Vet Microbiol; 1996 Nov; 53(1-2):199-206. PubMed ID: 9011012
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Early immunity induced by a live gE-negative bovine herpesvirus 1 marker vaccine.
    Kaashoek MJ; van Oirschot JT
    Vet Microbiol; 1996 Nov; 53(1-2):191-7. PubMed ID: 9011011
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Thymidine kinase-negative bovine herpesvirus type 1 mutant is stable and highly attenuated in calves.
    Kit S; Qavi H; Gaines JD; Billingsley P; McConnell S
    Arch Virol; 1985; 86(1-2):63-83. PubMed ID: 2994602
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Protection from parainfluenza-3 virus and persistence of infectious bovine rhinotracheitis virus in sheep vaccinated with a modified live IBR-PI-3 vaccine.
    Lehmkuhl HD; Cutlip RC
    Can J Comp Med; 1985 Jan; 49(1):58-62. PubMed ID: 2985216
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Characteristics of live bovine herpesvirus-1 vaccines.
    Patel JR
    Vet J; 2005 May; 169(3):404-16. PubMed ID: 15848783
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Relative efficacy of inactivated bovine herpesvirus-1 (BHV-1) vaccines.
    Patel JR
    Vaccine; 2005 Jul; 23(31):4054-61. PubMed ID: 15951068
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Effectiveness of a BHV-1/BEFV bivalent vaccine against bovine herpesvirus type 1 infection in cattle.
    Chung YC; Shen HY; Cheng LT; Liu SS; Chu CY
    Res Vet Sci; 2016 Dec; 109():161-165. PubMed ID: 27892866
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Efficacy of an inactivated, recombinant bovine herpesvirus type 5 (BoHV-5) vaccine.
    Campos FS; Dezen D; Antunes DA; Santos HF; Arantes TS; Cenci A; Gomes F; Lima FE; Brito WM; Filho HC; Batista HB; Spilki FR; Franco AC; Rijsewijk FA; Roehe PM
    Vet Microbiol; 2011 Feb; 148(1):18-26. PubMed ID: 20828945
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Early protection against infectious bovine rhinotracheitis with intramuscularly administered vaccine.
    Bordt DE; Thomas PC; Marshall RF
    Proc Annu Meet U S Anim Health Assoc; 1975; (79):50-60. PubMed ID: 220626
    [No Abstract]   [Full Text] [Related]  

  • 60. Efficacy of bovine herpesvirus-1 inactivated vaccine against abortion and stillbirth in pregnant heifers.
    Zimmerman AD; Buterbaugh RE; Herbert JM; Hass JM; Frank NE; Luempert Iii LG; Chase CC
    J Am Vet Med Assoc; 2007 Nov; 231(9):1386-9. PubMed ID: 17976001
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.